You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨金斯瑞生物科技高開3.54% 傳奇生物擬公開發售750萬股美國存托股份 預計獲得所得款3億美元
格隆匯 12-20 09:29
格隆匯12月20日丨金斯瑞生物科技(01548.HK)高開3.54%,報35.1港元,總市值738億港元。金斯瑞生物科技公佈,2021年12月16日,傳奇生物科技股份有限公司與Morgan Stanley & Co.LLC、J.P.Morgan Securities LLC、Jefferies LLC、Piper Sandler & Co.及Barclays Capital Inc.訂立承銷協議,內容有關向公眾承銷公開發售750萬股美國存托股份,代表1500萬股普通股,價格為每股美國存托股份40美元。傳奇生物預計從發售中獲得所得款項總額3億美元(扣除承銷折扣、佣金及預計發售費用前)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account